Tempus AI, Inc. income statement
In fiscal 2025, Tempus AI, Inc. reported revenue of $1.27bn, up 83.4% on the year before, operating income of −$253m (a -19.9% margin) and net income of −$245m, or −$1.41 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|
| Revenue | 321 | 532 | 693 | 1,272 | 1,509 |
| Research and development | 83 | 90 | 149 | 173 | 197 |
| Selling, general and administrative | 233 | 297 | 755 | 732 | 879 |
| Operating income | −265 | −196 | −691 | −253 | −279 |
| Interest expense | 22 | 47 | 54 | 70 | 47 |
| Income before tax | −289 | −214 | −701 | −291 | −184 |
| Income tax | 0 | 0 | 0 | −52 | −6 |
| Net income | −290 | −214 | −706 | −245 | −189 |
| Diluted EPS | −$2.65 | −$2.10 | −$6.23 | −$1.41 | −$1.05 |
| Diluted shares (average) | — | — | — | 174m | 180m |
| EBITDA | −249 | −175 | −665 | −221 | −249 |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 201 | 256 | 315 | 334 | 367 | 348 | 382 | 412 |
| Research and development | 30 | 36 | 42 | 45 | 50 | 48 | 53 | 46 |
| Selling, general and administrative | 111 | 155 | 181 | 188 | 209 | 213 | 226 | 232 |
| Operating income | −51 | −69 | −62 | −61 | −61 | −85 | −76 | −57 |
| Interest expense | 13 | 18 | 22 | 15 | 15 | 14 | 10 | 7 |
| Income before tax | −10 | −112 | −41 | −81 | −57 | −123 | 9 | −12 |
| Income tax | 0 | −46 | 0 | 0 | −6 | −0 | 0 | 0 |
| Net income | −13 | −68 | −43 | −80 | −54 | −126 | 6 | −15 |
| Diluted EPS | $0.81 | −$0.40 | −$0.25 | −$0.46 | −$0.31 | −$0.71 | $0.03 | −$0.08 |
| EBITDA | −44 | −61 | −53 | −53 | −54 | −77 | −69 | −50 |
Compare with peers
- Waystar Holding Corp. income statement
- Omnicell, Inc. income statement
- Teladoc Health, Inc. income statement
- Goodrx Holdings, Inc. income statement
- Veeva Systems Inc income statement
Head to head: TEM vs WAYOMCL vs TEMTDOC vs TEMTEM vs VEEV
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies